Tarextumab in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Eileen M. O’Reilly, MD, discusses results of a randomized phase II trial of tarextumab in combination with nab-paclitaxel and gemcitabine in patients with untreated metastatic pancreatic cancer.